MURINEDDU, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 6.890
AS - Asia 3.813
SA - Sud America 2.190
EU - Europa 2.011
AF - Africa 149
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 15.079
Nazione #
US - Stati Uniti d'America 6.756
BR - Brasile 1.917
SG - Singapore 1.382
CN - Cina 1.175
UA - Ucraina 690
VN - Vietnam 360
HK - Hong Kong 313
DE - Germania 291
IT - Italia 280
FR - Francia 180
SE - Svezia 148
TR - Turchia 123
FI - Finlandia 120
AR - Argentina 111
GB - Regno Unito 99
BD - Bangladesh 72
IN - India 72
IQ - Iraq 60
CA - Canada 47
ZA - Sudafrica 45
EC - Ecuador 40
MX - Messico 39
RU - Federazione Russa 39
UZ - Uzbekistan 34
BE - Belgio 31
MA - Marocco 31
CO - Colombia 30
VE - Venezuela 30
JP - Giappone 27
ID - Indonesia 24
KE - Kenya 24
PK - Pakistan 24
KR - Corea 20
PL - Polonia 20
JO - Giordania 17
PY - Paraguay 17
CL - Cile 16
ES - Italia 16
TN - Tunisia 15
AT - Austria 13
AU - Australia 13
CZ - Repubblica Ceca 13
PE - Perù 12
DO - Repubblica Dominicana 11
NL - Olanda 11
RO - Romania 10
UY - Uruguay 10
AL - Albania 9
KZ - Kazakistan 9
OM - Oman 9
DZ - Algeria 8
EU - Europa 8
IR - Iran 8
JM - Giamaica 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
IL - Israele 7
LB - Libano 7
BO - Bolivia 6
CR - Costa Rica 6
EG - Egitto 6
SA - Arabia Saudita 6
BH - Bahrain 5
KG - Kirghizistan 5
PS - Palestinian Territory 5
RS - Serbia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
LT - Lituania 4
MY - Malesia 4
NG - Nigeria 4
PA - Panama 4
PH - Filippine 4
BB - Barbados 3
BY - Bielorussia 3
GE - Georgia 3
HU - Ungheria 3
KH - Cambogia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AM - Armenia 2
BN - Brunei Darussalam 2
BS - Bahamas 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
IE - Irlanda 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
CG - Congo 1
CH - Svizzera 1
Totale 15.056
Città #
Dallas 2.765
Singapore 677
Chandler 675
San Jose 460
Jacksonville 420
Hong Kong 304
Ashburn 296
Princeton 238
Beijing 236
Dearborn 216
Nanjing 192
Ho Chi Minh City 134
New York 127
Lauterbourg 119
São Paulo 112
Ann Arbor 109
Wilmington 106
Hanoi 84
Shanghai 81
Izmir 76
Rio de Janeiro 73
Los Angeles 72
Sassari 64
Santa Clara 62
Nanchang 57
Shenyang 56
Belo Horizonte 53
Woodbridge 46
Brasília 44
Hebei 43
Tianjin 42
Changsha 39
Rome 36
Baghdad 31
Jiaxing 31
Tashkent 31
Brussels 30
Guarulhos 27
Johannesburg 27
Tokyo 26
Porto Alegre 24
Curitiba 23
Boardman 22
Buffalo 22
Kunming 22
Nairobi 22
Council Bluffs 21
Helsinki 21
Montreal 21
Denver 20
Santo André 20
Andover 19
Buenos Aires 19
Ningbo 19
Orem 19
Seoul 19
Campinas 18
Caxias do Sul 18
Guangzhou 18
Jinan 18
San Francisco 18
Sorocaba 18
Amman 17
Columbus 17
Houston 17
Ribeirão Preto 17
San Mateo 17
Warsaw 17
Da Nang 16
Frankfurt am Main 16
Hangzhou 16
Istanbul 16
Mountain View 16
Munich 16
Norwalk 16
The Dalles 16
Toronto 16
Guayaquil 15
Quito 15
Haiphong 14
London 14
Bogotá 13
Brooklyn 13
Contagem 13
Dhaka 13
Fortaleza 13
Goiânia 13
Salvador 13
Zhengzhou 13
Asunción 12
Casablanca 12
Manaus 12
Mumbai 12
Osasco 12
Recife 12
Stockholm 12
São José do Rio Preto 12
Taizhou 12
Chennai 11
Chicago 11
Totale 9.296
Nome #
Synthesis of Novel Tricyclic N-Acylhydrazones as Tubulin Polymerization Inhibitors 458
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity 286
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 249
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 241
Design and synthesis of novel FGFR inhibitors for the treatment of glioblastoma 235
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and biological evaluation 207
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 189
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6- tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. 180
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers 174
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 167
Composti farmaceutici 164
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 161
Approcci terapeutici contro il cancro. Tradizione e innovazione. 158
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 153
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands 151
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 148
Antiviral activity of benzotriazole based derivatives 147
3-(5-Phenyl[1,3,4]oxadiazol-2-yl)-1H-benzo]g]indole and related compounds: synthesis and cytotoxic acitivities 145
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 144
Oxadiazoles having antiproliferative activity 144
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 144
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 143
A survey of Recent Patents on CB2 Agonists in the Management of Pain 140
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 139
Chiral pyridine N-oxides useful ligands for asymmetric catalysis 139
CAPITOLO 41. Antielmintici 137
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 135
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 135
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 132
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors 132
Pharmaceutical compounds 131
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 131
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues 129
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 129
Chimica farmaceutica 128
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 126
Tricyclic pyrazoles. Part 3. Synthesis, biological evaluation and molecular modelling of analogues of the cannabinoid antagonist NESS 0327 126
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 124
The organic chemistry of drug design and drug action 122
Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors 122
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 120
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors 118
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 118
An overview on different classes of viral entry and respiratory syncitial virus (RSV) fusion inhibitors 117
Diazacyclic compounds having affinity for opioid receptors 117
Chromophore-modified bis-benzo[g]indolecarboxamides: synthesis and citotoxicity of bis-benzo[g]indazole-3-carboxamides and related compounds 117
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 117
Pharmaceutical Compounds 116
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as μ-opioid receptor agonists. Effects on μ-affinity of arylalkenyl chain modifications 116
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 116
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides 114
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 114
Oxadiazoles having anti proliferative activity 112
Design of a new class of chiral C2-symmetric dipyridylmethane ligands and their application in asymmetric catalysis 112
Development and characterization of novel cannabinoid derivatives based on diarylpyridazine scaffold. 112
Pharmaceutical Compounds 111
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 111
Synthesis of biologically active bridged diazabicycloheptanes 111
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines 110
Pharmaceutical compounds 110
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 110
Ring-fused pyrazole derivates as ligands for cannabinoid receptors: synthesis and investigation of structure-activity relationships 107
I farmaci antivirali. Dalla progettazione all’impiego terapeutico. 107
Synthesis and cytotoxicity evaluation of thiophene analogues of 1-methyl-2,3-bis(hydroxymethyl)benzo[g]indole bis[N-(2-propyl)carbamate] 106
Synthesis and cytotoxicity of substituted 2-benzylnaphth[2,3-d]imidazoles 105
Synthesis and biological evaluation of diazabiciclo[3.3.1]nonanes with a thiother bridge 104
Synthesis, modelling, and m-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes 103
Pharmaceutical compounds 103
Novel diazabicycloalkane delta opioid agonists 103
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2 ',4 '-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyra zole-3-carboxamide 103
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety 103
Manuale di chimica farmaceutica. Progettazione, meccanismo d'azione e metabolismo dei farmaci 102
Sintesi di 1,10-fenantroline chirali a simmetria C2 derivati da monoterpeni naturali quali utili leganti per la catalisi asimmetrica 102
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzolglindazole-based ligands for cannabinoid receptors 101
Pharmaceutical compounds 101
Chimica farmaceutica. Con e-book 100
Pirazoli triciclici: sintesi e valutazione biologica di ligandi per i recettori cannabinoidei con struttura diidroindenopirazolica contenenti differenti sostituenti carbossammidici 100
Synthesis and application in asymmetric copper(I)-catalyzed allylic oxidation of a new chiral 1,10-phenantroline derived from pinene 98
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and antileukemia evaluation 97
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors 97
Pharmaceutical compounds 97
Ossadiazoli ad attività antiproliferativa 96
Synthesis and tumor cell lines inhibition of 1,3,4.oxadiazoles linked to tricyclic pyrroles 96
Pyrazolo-naphthyridines: Design and Synthesis of potential CB-ligands 95
Pharmaceutical compounds 95
I 3,6-diazabiciclo[3.1.1]eptani: una nuova serie di potenti agonisti per i recettori µ degli oppioidi 94
Synthesis of chiral C2-symmetric 1,10-phenanthrolines from naturally occurring monoterpenes 93
Pharmaceutical compounds 92
Substituted 3,8-diazabicyclo[3.2.1]octane compounds 91
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors 91
Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties 91
Different classes of CB2 Ligands Potentially Useful in the Treatment of Pain. 90
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives 90
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes 90
Synthesis, Pharmacological Evaluation and Docking Studies of Pyrrole Structure-Based CB2 Receptor Antagonists 90
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors 89
New tricyclic pyrazole derivatives as CB1 antagonists having improved activity towards food intake and weight control 88
Pirazoli Triciclichi. Sintesi e valutazione biologica di ligandi per i recettori cannabinoidi con struttura diidroindenopirazolica contenente differenti sostituenti carbossamidici 88
Synthesis, pharmacological evaluation and docking studies of pirrole structure-based CB2 receptor antagonists. 88
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazoles: A versatile architecture for CB2 selective ligands 88
Totale 12.718
Categoria #
all - tutte 58.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 0 0 0 0 0 20
2021/2022572 67 6 9 7 8 5 28 48 51 37 61 245
2022/20231.271 130 78 27 229 110 210 2 161 228 8 56 32
2023/2024396 58 26 15 7 37 81 1 55 3 4 50 59
2024/20253.579 20 20 186 59 124 117 277 583 1.351 573 161 108
2025/20266.495 222 1.544 1.679 875 387 312 669 146 248 245 144 24
Totale 15.202